p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4763-4771

  Mori, Akio ^a,b   Kaminuma, Osamu ^b   Miyazawa, Keiji ^b   Ogawa, Koji ^b   Okudaira, Hirokazu ^b   Akiyama, Kazuo ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PHORBOL ESTER; RECOMBINANT INTERLEUKIN 2;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NORTHERN BLOTTING; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA ANALYSIS; T LYMPHOCYTE ACTIVATION;

CLONE CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; IMIDAZOLES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASES; MUROMONAB-CD3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032711893     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Azzawi, M., B. O. Bradley, P. K. Jeffery, A. J. Frew, A. J. Wardlaw, G. Knowles, B. Assoufi, J. V. Collins, S. Durham, and A. B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis, 142:1410.
2. Jeffery, P. K., A. J. Wardlaw, F. C. Nelson, J. V. Collins, and A. B. Kay. 1989. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis. 140:1745.
3. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
4. +) T cells and eosinophils in allergy and asthma. Am. Rev. Respir. Dis. 145:S22.
5. Corrigan, C. T., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501.
6. Sanderson, C. J., H. D. Campbell, and I. G. Young. 1988. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol. Rev. 102:29.
7. Takatsu, K., S. Takaki, and Y. Hitoshi. 1994. Interleukin-5 and its receptor system: implication in the immune system and inflammation. Adv. Immunol. 57:145.
8. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, et al. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541.
9. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397.
10. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313.
11. Humbert, M., C. J. Corrigan, P. Kimmitt, S. J. Till, A. B. Kay, and S. R. Durham. 1997. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am. J. Respir. Crit. Care Med. 156:704.
12. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow. 1992. Allergic and non-allergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109.
13. Ohnishi, T., H. Kita, D. Weiler, S. Sur, J. B. Sedgwick, W. J. Calhoun, W. W. Busse, J. S. Abrams, and G. J. Gleich. 1993. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:901.
14. Corrigan, C. J., A. Haczku, V. Gemou-Engesaeth, S. Doi, Y. Kikuchi, K. Takatsu, S. R. Durham, and A. B. Kay. 1993. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: effect of glucocorticoid therapy. Am. Rev. Respir. Dis. 147:540.
15. Krishnaswamy, G., M. C. Liu, S.-N. Su, M. Kumai, H.-Q. Xiao, D. G. Marsh, and S. K. Huang. 1993. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am. J. Respir. Cell Mol. Biol. 9:279.
16. Gulbenkian, A. R., R. W. Egan, X. Fernandez, H. Jones, W. Kreutner, T. Kung, F. Payvandi, L. Sullivan, J. A. Zurcher, and A. S. Watnick. 1992. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:263.
17. Chand, N., J. E. Harrison, S. Rooney, J. Pillar, R. Jakubicki, K. Nolan, W. Diamantis, and R. D. Sofia. 1992. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Phamacol. 211:121.
18. Mauser, P. J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A. S. Watnick, R. W. Egan, W. Kreutner, and G. K. Adams. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623.
19. Van Oosterhout, A. J. M., A. R. C. Ladenius, H. F. J. Savelkoul, I. V. Ark, K. C. Delsman, and F. P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147:548.
20. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449.
21. Kay, A. B., S. Ying, V. Varney, M. Gaga, S. R. Durham, R. Moqbel, A. J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775.
22. Schleimer, P. R. 1990. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am. Rev. Respir. Dis. 141:S59.
23. Snyder, D. S., and E. R. Unanue. 1982. Corticosteroids inhibit murine la expression and IL-1 production. J. Immunol. 129:1803.
24. Vacca, A., S. Martinotti, I. Screpanti, M. Maroder, M. P. Felli, A. R. Farina, A. Gismondi, A. Santoni, L. Frati, and A. Gulino. 1990. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. J. Immunol. 265:8075.
25. Mori, A., O. Kaminuma, M. Suko, S. Inoue, T. Ohmura, A. Hoshino, Y. Asakura, K. Miyazawa, Y. Okumura, K. Ito, and H. Okudaira. 1997. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89:2891.
26. Staynov, D. Z., and T. H. Lee. 1992. Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in human peripheral blood mononuclear cells after activation with phorbol myristate acetate. Immunology 75:196.
27. Okayama, H., T. Fushimi, S. Shimura, H. Sasaki, and K. Shirato. 1994. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J. Allergy Clin. Immunol. 93:1006.
28. Mizoguchi, M., K. Kawaguchi, Y. Ohsuga, Y. Ikari, A. Yanagawa, and Y. Mizushima. 1992. Cyclosporin ointment for psoriasis and atopic dermatitis. Lancet 339:1120.
29. Nakagawa, H., T. Etoh, Y. Ishibashi, Y. Higaki, M. Kawashima, H. Torii, and S. Harada. 1994. Tacrolimus ointment for atopic dermatitis. Lancet 344:883.
30. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McMulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
31. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zama-nillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027.
32. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420.
33. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808.
34. Freshney, N. W., L. Rawlinson, F. Guesdon, E. Jones, S. Cowley, J. Hsuan, and J. Saklatvala. 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039.
35. Gupta, S., D. Campbell, B. Derijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389.
36. Wang, X. Z., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272: 1347.
37. Zervos, A. S., L. Faccio, J. P. Gatto, J. M. Kyriakis, and R. Brent. 1995. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc. Natl. Acad. Sci. USA 92:10531.
38. Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296.
39. Price, M. A., F. H. Cruzalegui, and R. Treisman. 1996. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J. 15:6552.
40. Janknecht, R., and T. Hunter. 1997. Convergence of MAP kinase pathways on the ternary complex factor Sap-la. EMBO J. 16:1062.
41. Whitmarsh, A. J., S.-H. Yang, M. S.-S. Su, A. D. Sharrocks, and R. J. Davis. 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:2360.
42. Stein, B., M. X. Yang, D. B. Young, R. Janknecht, T. Hunter, B. W. Murray, and M. S. Barbosa. 1997. p38-2 a novel mitogen-activated protein kinase with distinct properties. J. Biol. Chem. 272:19509.
43. Kumar, S., P. C. McDonnell, R. J. Gum, A. T. Hand, J. C. Lee, and P. R. Young. 1997. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235:533.
44. Li, Z., Y. Jiang, R. J. Ulevitch, and J. Han. 1996. The primary structure of p38 γ: a new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228:334.
45. Cuenda, A., P. Cohen, V. Buee-Scherrer, and M. Goedert. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:295.
46. Wang, X. S., K. Diener, C. L. Manthey, S. Wang, B. Rosenzweig, J. Bray, J. Delaney, C. N. Cole, P. Y. ChanHui, N. Mantlo, et al. 1997. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272:23668.
47. Goedert, M., A. Cuenda, M. Craxton, R. Jakes, and P. Cohen. 1997. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stress is mediated by SKK (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16:3563.
48. Goedert, M., M. Hasegawa, R. Jakes, S. Lawler, A. Cuenda, and P. Cohen. 1997. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinase. FEBS Lett. 409:57.
49. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
50. Young, P., P. McDonnell, D. Dunning, A. Hand, J. Laydon, and J. Lee. 1993. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level. Agents Actions 39:C67.
51. Prichett, W., A. Hand, J. Sheilds, and D. Dunnington. 1995. Mechanism of action of bicycle imidazoles defines a translation regulatory pathway for tumor necrosis factor α. J. Inflamm. 45:97.
52. Lee, J. C., and P. R. Young. 1996. Role of CBS/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:152.
53. Beyaert, R., A. Cuenda, W. Vanden-Berghe, S. Plaisance, J. C. Lee, G. Haegeman, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1914.
54. Berghe, W. V., S. Plaisance, E. Boone, K. De-Bosscher, M. L. Schmitz, W. Fiers, and G. Haegeman. 1998. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:3285.
55. Salmon, R. A., I. N. Foltz, P. R. Young, and J. W. Schrader. 1997. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, fas or CD28, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J. Immunol. 159:5309.
56. Yuuki, T., Y. Okumura, T. Ando, H. Yamakawa, M. Suko, M. Haida, and H. Okudaira. 1991. Cloning and expression of cDNA for the major house dust mite allergen Der f II in Escherichia coli. Agric. Biol. Chem. 55:1233.
57. Mori, A., M. Suko, O. Kaminuma, S. Inoue, T. Ohmura, Y. Nishizaki, T. Nagahori, Y. Asakura, A. Hoshino, Y. Okumura, et al. 1995. IL-15 promotes cytokine production of human helper T cells. J. Immunol. 156:2391.
58. Fukuda, Y., J. Hashino, M. Haruyama, N. Tsuruoka, H. Nakazato, and T. Nakanishi. 1991. A sandwich enzyme-linked immunosorbent assay for human interleukin-5. J. Immunol. Methods 143:89.
59. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
60. Azuma, C., T. Tanabe, M. Konishi, T. Kinashi, T. Noma, F. Matsuda, Y. Yaoita, K. Takatsu, L. Hammarstroem, C. I. E. Smith, et al. 1986. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res. 14:9149.
61. Lewis, S. A., M. G.-S. Lee, and N. J. Cowan. 1985. Five mouse tubulin isotypes and their regulated expression during development. J. Cell Biol. 101:852.
62. Miyazawa, K., A. Mori, H. Miyata, Y. Ajisawa, and H. Okudaira. 1998. Regulation of interleukin-1-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273: 24832.
63. Altman, A., K. M. Coggeshall, and T. Mustelin. 1990. Molecular events mediating T cell activation. Adv. Immunol. 48:227.
64. Dean, J. L. E., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274: 264.
65. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigen, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
66. Mauser, P. J., A. Pitman, X. Fernandez, S. K. Foran, G. K. Adams III, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467.
67. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. J. Immunol. 146:374.
68. Mori, A., O. Kaminuma, M. Suko, T. Mikami, Y. Nishizaki, T. Ohmura, A. Hoshino, Y. Asakura, T. Ando, Y. Okumura, et al. 1997. Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: a study using allergen-specific human helper T cells. J. Allergy Clin. Immunol. 100:S56.
69. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
70. Crawley, J. B., L. Rawlinson, F. V. Lali, T. H. Page, J. Saklatvala, and B. M. J. Foxwell. 1997. T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J. Biol. Chem. 272:15023.
71. Mori, A., M. Suko, O. Kaminuma, Y. Nishizaki, T. Mikami, T. Ohmura, A. Hoshino, S. Inoue, N. Tsuruoka, Y. Okumura, et al. 1996. A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones. Int. Immunol. 8:1889.
72. + T cells is suppressed by FK506. J. Immunol. 158:3659.
73. Rincón, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. S.-S. Su, L. A. Penix, R. J. Davis, and R. A. Flavell. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817.
74. + T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell. Biol. 17:1522.
75. Matsuda, S., T. Moriguchi, S. Koyasu, and E. Nishida. 1998. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273:12378.
76. Schafer, P. H., L. Wang, A. S. Wadswoth, E. J. Davis, and J. J. Siekierka. 1999. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-α production in a manner distinct from LPS activation of monocytes. J. Immunol. 162:659.